Pfeiffertheface.com

Discover the world with our lifehacks

What is lanreotide Autogel?

What is lanreotide Autogel?

Lanreotide Autogel(®) (ATG) [Somatuline(®) Autogel(®), Somatuline(®) Depot(®)] is a prolonged-release, supersaturated aqueous gel formulation of the somatostatin analogue lanreotide acetate that acts via somatostatin receptors to reduce both growth hormone and insulin-like growth factor-I levels.

How much does lanreotide injection cost?

The cost for lanreotide subcutaneous solution (120 mg/0.5 mL) is around $9,080 for a supply of 0.5 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

What class of drug is lanreotide?

Lanreotide injection is in a class of medications called somatostatin agonists. It works by decreasing the amounts of certain natural substances produced by the body.

Is lanreotide an SSA?

Another SSA in clinical use, lanreotide (Somatuline®; Ipsen), has a similar activity and affinity profile, although it has not yet been approved by the FDA for the treatment of patients with NETs.

Is lanreotide covered by Medicare?

No. In general, Medicare prescription drug plans (Part D) do not cover this drug. Be sure to contact your specific plan to verify coverage information. A limited set of drugs administered in a doctor’s office or hospital outpatient setting may be covered under Medical Insurance (Part B).

Is lanreotide a chemotherapy?

Lanreotide (Somatuline Depot Injection) Chemotherapy Drug Information.

How much does Somatuline Depot cost?

The cost for Somatuline Depot subcutaneous solution (60 mg/0.2 mL) is around $6,144 for a supply of 0.2 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

Is lanreotide a biologic?

Lanreotide is manufactured by the company, Ipsen Pharmaceuticals as lanreotide acetate, and marketed as Somatuline. It is approved in several countries worldwide, including the United Kingdom, Australia, and Canada….2Biologic Description.

SVG Image
Sequence XCYWKVCX

Is lanreotide a chemotherapy drug?

What drugs are not covered by Medicare?

Medicare does not cover:

  • Drugs used to treat anorexia, weight loss, or weight gain.
  • Fertility drugs.
  • Drugs used for cosmetic purposes or hair growth.
  • Drugs that are only for the relief of cold or cough symptoms.
  • Drugs used to treat erectile dysfunction.

Does Medicare Part D cover biologics?

Nationally, nearly all Part D plans cover at least one biologic DMARD, but the vast majority require sufficiently high cost sharing to risk significant financial burden to patients.

How long can you take lanreotide?

The recommended dose of lanreotide is: Acromegaly: 90 mg every 4 weeks for 3 months. Adjust thereafter based on growth hormone and/or insulin growth factor-1 (IGF-1) levels.

Lanreotide Autogel (ATG) [Somatuline Depot] is a novel, long-acting preparation of the somatostatin analogue lanreotide acetate that acts via somatostatin receptors to reduce both growth hormone (GH) and insulin-like growth factor-I (IGF-I) levels.

How long does it take for Somatuline®Autogel® (lanreotide) to work?

The study duration for efficacy was 52 weeks (4 weeks baseline screening, 16 weeks double-blind treatment, and 32 weeks open-label treatment), followed by an extended open-label safety phase. SOMATULINE®AUTOGEL®(lanreotide injection) Page 33 of 57

How common are antibodies in patients treated with Somatuline®Autogel® (lanreotide injection)?

Laboratory investigations of acromegalic patients treated with SOMATULINE®AUTOGEL®in clinical studies show that the percentage of patients with putative antibodies at any time point after treatment is low (<1% to 4% of patients in specific studies whose antibodies were tested). SOMATULINE®AUTOGEL®(lanreotide injection) Page 36 of 57

What is the role of lanreotide in the treatment of acromegaly?

Lanreotide ATG provided hormonal control and improved both health-related quality of life and acromegaly symptoms in most patients; it also reduced tumour volume to a clinically significant extent in studies of primary therapy.

https://www.youtube.com/watch?v=pMQxrmMiR6Y